JPH06508844A - ベータ−ラクタム抗生物質およびクラブラン酸またはその水溶性塩の医薬製剤 - Google Patents

ベータ−ラクタム抗生物質およびクラブラン酸またはその水溶性塩の医薬製剤

Info

Publication number
JPH06508844A
JPH06508844A JP5502080A JP50208093A JPH06508844A JP H06508844 A JPH06508844 A JP H06508844A JP 5502080 A JP5502080 A JP 5502080A JP 50208093 A JP50208093 A JP 50208093A JP H06508844 A JPH06508844 A JP H06508844A
Authority
JP
Japan
Prior art keywords
acid
pharmaceutical
formulation according
salts
pharmaceutical formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5502080A
Other languages
English (en)
Japanese (ja)
Inventor
クラファム，ディビッド
Original Assignee
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー filed Critical スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Publication of JPH06508844A publication Critical patent/JPH06508844A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP5502080A 1991-07-11 1992-07-03 ベータ−ラクタム抗生物質およびクラブラン酸またはその水溶性塩の医薬製剤 Pending JPH06508844A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919114950A GB9114950D0 (en) 1991-07-11 1991-07-11 Pharmaceutical formulation
GB9114950.0 1991-07-11
PCT/GB1992/001207 WO1993000898A1 (fr) 1991-07-11 1992-07-03 Formulation pharmaceutique comprenant une beta-lactamine et de l'acide clavulanique ou un sel de celui-ci soluble dans l'eau

Publications (1)

Publication Number Publication Date
JPH06508844A true JPH06508844A (ja) 1994-10-06

Family

ID=10698173

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5502080A Pending JPH06508844A (ja) 1991-07-11 1992-07-03 ベータ−ラクタム抗生物質およびクラブラン酸またはその水溶性塩の医薬製剤

Country Status (5)

Country Link
EP (1) EP0593573A1 (fr)
JP (1) JPH06508844A (fr)
AU (1) AU2230692A (fr)
GB (1) GB9114950D0 (fr)
WO (1) WO1993000898A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009042A1 (fr) 1995-09-07 1997-03-13 Smithkline Beecham Corporation Preparation pharmaceutique
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
US20010016577A1 (en) * 1998-08-24 2001-08-23 Douglas Joseph Dobrozsi Oral mucoadhesive compositions containing gastrointestinal actives
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (fr) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
KR101420446B1 (ko) 2005-09-22 2014-07-16 메이지 세이카 파루마 가부시키가이샤 메탈로-β-락타마제 저해제
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
WO2011142731A2 (fr) 2010-05-14 2011-11-17 Mahmut Bilgic Formulations comprenant une céphalosporine et un acide clavulanique de troisième génération
EP2568957A1 (fr) 2010-05-14 2013-03-20 Mahmut Bilgic Composition pharmaceutique comprenant la céfixime et un composé dérivé de l'acide clavulanique
EP2575777A1 (fr) 2010-06-03 2013-04-10 Mahmut Bilgic Formulation comprenant du cefpodoxime proxétil et de l'acide clavulanique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080862B1 (fr) * 1981-12-02 1985-09-25 Beecham Group Plc Préparation pharmaceutique contenant des antibiotiques béta-lactame
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
GB9114950D0 (en) 1991-08-28
AU2230692A (en) 1993-02-11
WO1993000898A1 (fr) 1993-01-21
EP0593573A1 (fr) 1994-04-27

Similar Documents

Publication Publication Date Title
JPH06508844A (ja) ベータ−ラクタム抗生物質およびクラブラン酸またはその水溶性塩の医薬製剤
US4861592A (en) Pharmaceutical compositions
US4676984A (en) Rehydratable antacid composition
US6726908B2 (en) Pharmaceutical formulation
PT1841432E (pt) Composições para combater a resistência aos antibióticos mediada pela beta-lactamase usando inibidores da betalactamase úteis para injecção
JPH06504991A (ja) 組成物
CZ59299A3 (cs) Použití kombinace amoxycilinu a klavulanatu pro přípravu léčiva pro léčení infekcí streptokoku pneumonia resiztentních na léčiva
EP1057828B1 (fr) Suspensions de trovafloxacine administrées par voie orale
JPH10298110A (ja) 液体制酸薬製剤
JPH10316577A (ja) 液体制酸薬組成物
BG63821B1 (bg) Фармацевтичен състав на стабилизиран карбапенемовантибиотик и метод за получаване
SK146297A3 (en) Composition comprising amoxycillin and clavulanic acid
US4704278A (en) Fluidized magaldrate suspension
IL31858A (en) Concentrated liquid mixtures against acids
EP1452169B1 (fr) Compositions pharmaceutiques liquides de base aqueuse en forme de suspension destinnees a l'administration par voie orale d'ibuprofene
TW477700B (en) Improved process for preparing potassium clavulancate
US4272542A (en) Use of di-sodium and di-potassium salts of dicarboxylic amino acids and tri- or di-sodium or potassium phosphate tartrate or citrate to improve the taste of in vivo hydrolysable esters of α-amino penicillins and cephalosporins
JPS61118321A (ja) 流動化マガルドラート組成物
US20030104017A1 (en) Epinastine formulation for oral administration
IL30684A (en) Therapeutic compositions containing ampicillin or hetacillin and nystatin
EP0008178A2 (fr) Poudre, procédé pour sa préparation, récipient la contenant, et sirop comprenant la poudre reconstituée avec de l'eau
US6265449B1 (en) Aqueous compositions comprising ranitidine and LCMT sucrose
WO2000050036A1 (fr) Composition sous forme de suspension a stockage stable a base d'amoxycilline et de clavulanate
JP3364453B2 (ja) センノシド含有水性液剤
CA1252045A (fr) Suspension fluidisee de magaldrate